Goldman Takes Haemonetics Off Sell List, Upgrades To Neutral

By: via Benzinga
Goldman Sachs has upgraded Haemonetics Corporation (NYSE: HAE) to Neutral and removed the stock from "Americas Sell List," saying that ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.